Eudaimonia Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Eudaimonia Partners's LLY Position: Q1 2024 in Review
Eudaimonia Partners reduced its Eli Lilly (LLY) stake by 7.4% in Q1 2024, selling an estimated $41.3K and leaving 726 shares worth $565K. The position accounts for 0.13% of the portfolio, ranked #147.
Eudaimonia Partners first reported a position in LLY in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.33M in Q2 2022. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.
- Eudaimonia Partners held 726 shares of Eli Lilly worth $565K as of Q1 2024.
- Eudaimonia Partners sold 58 Eli Lilly shares in Q1 2024, an estimated $41.3K.
- Eli Lilly made up 0.13% of Eudaimonia Partners's portfolio in Q1 2024, its #147 holding.
- Eudaimonia Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 17 quarters since.
- Eudaimonia Partners's Eli Lilly position peaked at $1.33M in Q2 2022.
- 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.
Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.